Michael Fehlings

3.7k citations

21 papers · 756 indexed · h-index 10

Impact in

Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in ⓘ

Immunology 13
- Immune Cell Function and Interaction 9
- Immunotherapy and Immune Responses 7
- T-cell and B-cell Immunology 6
Oncology 9
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 4

Co-authors: Evan W. Newell (12 shared papers)Alessandra Nardin (9 shared papers)Yannick Simoni (5 shared papers)Hermi Sumatoh (4 shared papers)Maxim N. Artyomov (1 shared paper)Cora D. Arthur (1 shared paper)Elise Alspach (1 shared paper)Robert S. Fulton (1 shared paper)
Journals: Journal for ImmunoTherapy of Cancer (2 papers)Scientific Reports (1 paper)Current Opinion in Immunology (1 paper)Nature Communications (1 paper)Cell Reports (1 paper)
Partner nations: Singapore United States Germany

In The Last Decade

Michael Fehlings

20 papers receiving 750 citations

Peers

Countries citing papers authored by Michael Fehlings

Since Specialization

Citations

This map shows the geographic impact of Michael Fehlings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fehlings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fehlings more than expected).

Fields of papers citing papers by Michael Fehlings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fehlings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fehlings. The network helps show where Michael Fehlings may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Fehlings, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Fehlings Line = papers co-authored together Michael Fehlings links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy Cell ·Matthew M. Gubin, Ekaterina Esaulova, Jeffrey P. Ward, Olga Malkova, Daniele Runci, Pamela Wong, Takuro Noguchi, Cora D. Arthur, Wei Meng, Elise Alspach, Ruan F.V. Medrano, Catrina C. Fronick, Michael Fehlings, Evan W. Newell, Robert S. Fulton, Kathleen C. F. Sheehan, Stephen T. Oh, Robert D. Schreiber, Maxim N. Artyomov	2018	275
2	Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice Gastroenterology ·David Kung‐Chun Chiu, Vincent Wai‐Hin Yuen, Jacinth Wing‐Sum Cheu, Larry Lai Wei, Vox Ting, Michael Fehlings, Hermi Sumatoh, Alessandra Nardin, Evan W. Newell, Irene Oi‐Lin Ng, Thomas Yau, Chun‐Ming Wong, Carmen Chak‐Lui Wong	2020	129
3	Mass cytometry: a powerful tool for dissecting the immune landscape Current Opinion in Immunology ·Yannick Simoni, Melissa Hui Yen Chng, Shamin Li, Michael Fehlings, Evan W. Newell	2018	65
4	Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 ⁺ T-Cell Epitopes Identified in COVID-19 Convalescent Individuals mBio ·Andrew D. Redd, Alessandra Nardin, Hassen Kared, Evan M. Bloch, Bernd Abel, Andrew Pekosz, Oliver Laeyendecker, Michael Fehlings, Thomas C. Quinn, Aaron A.R. Tobian	2022	64
5	CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants Open Forum Infectious Diseases ·Andrew D. Redd, Alessandra Nardin, Hassen Kared, Evan M. Bloch, Andrew Pekosz, Oliver Laeyendecker, Bernd Abel, Michael Fehlings, Thomas C. Quinn, Aaron A.R. Tobian	2021	63
6	Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment Journal for ImmunoTherapy of Cancer ·Michael Fehlings, Suchit Jhunjhunwala, Marcin Kowanetz, William O’Gorman, Priti S. Hegde, Hermi Sumatoh, Boon Heng Lee, Alessandra Nardin, Étienne Becht, Susan Flynn, Marcus Ballinger, Evan W. Newell, Mahesh Yadav	2019	56
7	Single-cell analysis reveals clonally expanded tumor-associated CD57 ⁺ CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade Journal for ImmunoTherapy of Cancer ·Michael Fehlings, Leesun Kim, Xiangnan Guan, Kobe Yuen, Alireza Tafazzol, Shomyseh Sanjabi, Oliver A. Zill, Deepali Rishipathak, Andrew J. Wallace, Alessandra Nardin, Siming Ma, Ana Milojkovic, Evan W. Newell, Sanjeev Mariathasan, Mahesh Yadav	2022	26
8	Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy Nature Communications ·Elaine Lai‐Han Leung, Runze Li, Xing‐Xing Fan, Lily Yan Wang, Yan Wang, Zebo Jiang, Jumin Huang, Hudan Pan, Yue Fan, Hongmei Xu, Feng Wang, Haopeng Rui, Piu Wong, Hermi Sumatoh, Michael Fehlings, Alessandra Nardin, Paul R. Gavine, Longen Zhou, Yabing Cao, Liang Liu	2023	14
9	In-depth analysis of human virus-specific CD8+ T cells delineates unique phenotypic signatures for T cell specificity prediction Cell Reports ·Florian Schmidt, Hannah Fields, Yovita Ida Purwanti, Ana Milojkovic, Syazwani Salim, Kan Xing Wu, Yannick Simoni, Antonella Vitiello, Daniel T. MacLeod, Alessandra Nardin, Evan W. Newell, Katja Fink, Andreas Wilm, Michael Fehlings	2023	11
10	Multiplex peptide-MHC tetramer staining using mass cytometry for deep analysis of the influenza-specific T-cell response in mice Journal of Immunological Methods ·Michael Fehlings, Svetoslav Chakarov, Yannick Simoni, B. N. Sivasankar, Florent Ginhoux, Evan W. Newell	2017	11
11	Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer European Thyroid Journal ·Janice Ser Huey Tan, Timothy Kwang Yong Tay, Enya H.W. Ong, Michael Fehlings, Daniel Shao-Weng Tan, Nadiah Binte Sukma, Eileen Xueqin Chen, Jen-Hwei Sng, Connie Siew Poh Yip, Kok Hing Lim, Wan‐Teck Lim, N. Gopalakrishna Iyer, Jacqueline Siok Gek Hwang, Melvin L.K. Chua, Mei‐Kim Ang	2024	8
12	Multiplex MHC Class I Tetramer Combined with Intranuclear Staining by Mass Cytometry Methods in molecular biology ·Yannick Simoni, Michael Fehlings, Evan W. Newell	2019	8
13	Ontogeny of different subsets of yellow fever virus-specific circulatory CXCR5+ CD4+ T cells after yellow fever vaccination Scientific Reports ·Quinn DeGottardi, Theresa J. Gates, Junbao Yang, Eddie A. James, Uma Malhotra, I‐Ting Chow, Yannick Simoni, Michael Fehlings, Evan W. Newell, Hannah A. DeBerg, William W. Kwok	2020	7
14	Unbiased Profiling Reveals Compartmentalization of Unconventional T-Cells Within the Intestinal Mucosa Irrespective of HIV Infection Frontiers in Immunology ·Magalli Magnoumba, Alveera Singh, Paul Ogongo, Julia Roider, Osaretin E. Asowata, Michael Fehlings, Farina Karim, Thumbi Ndung’u, Frank Anderson, Alasdair Leslie, Henrik N. Kløverpris	2020	7
15	Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies Journal of Visualized Experiments ·Andrzej Chruscinski, Flora Huang, Antigona Ulndreaj, Conan Chua, Michael Fehlings, Vivek Rao, Heather J. Ross, Gary Levy	2016	5
16	Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in non-small cell lung carcinoma patients responding to atezolizumab treatment European Journal of Cancer ·Michael Fehlings, Alessandra Nardin, Suchit Jhunjhunwala, Marcin Kowanetz, Bria O'Gorman, P. Hegde, J. Li, Hermi Sumatoh, Bob S. L. Lee, L. Kim, Shannon L. Flynn, M. Ballinger, Evan W. Newell, M. Yadav	2019	2
17	Usage of murine T-cell hybridoma cells as responder cells reveals interference of Helicobacter pylori with human dendritic cell-mediated antigen presentation European Journal of Microbiology and Immunology ·Michael Fehlings, Lea Drobbe, Macarena Beigier‐Bompadre, Pablo Renner Viveros, Verena Moos, Thomas Schneider, Thomas F. Meyer, Toni Aebischer, Ralf Ignatius	2016	2
18	Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity Vaccines ·Olaf‐Oliver Wolz, Dominik Vahrenhorst, Gianluca Quintini, Christina Lemberg, Sven D. Koch, Sarah-Katharina Kays, Lisa Walz, Neeraja Kulkarni, Michael Fehlings, Peter Wengenmayer, Jana Heß, Lidia Oostvogels, Sandra Lazzaro, Philipp von Eisenhart-Rothe, Philipp Mann	2024	1
19	Abstract 527: High-dimensional profiling of the systemic immune response informs on optimal sequencing of radiotherapy (RT) and immune checkpoint blockade (ICB) Cancer Research ·Kevin Lee Min Chua, Michael Fehlings, Pek Lim Chu, Xiaotian Lin, Eugenia L.L. Yeo, Kar Perng Low, Dennis Poon, Enya H.W. Ong, Wai Yee Woo, Joseph Wee, Alessandra Nardin, N. Gopalakrishna Iyer, Daniel S.W. Tan, Kee Chee Soo, Evan W. Newell, Melvin L.K. Chua	2019	1
20	Immune profiling of tumor-infiltrating T cells using mass cytometry. Journal of Clinical Oncology ·David Roumanes, Evan W. Newell, Michael Fehlings	2019	1

About Michael Fehlings

Michael Fehlings is a scholar working on Immunology, Oncology, Molecular Biology, Infectious Diseases and Surgery, having authored 21 papers that have together received 756 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (6 papers), Single-cell and spatial transcriptomics (4 papers), CAR-T cell therapy research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Immunology (442 citations), Oncology (370 citations), Infectious Diseases (134 citations), Cancer Research (62 citations) and Hepatology (32 citations). Michael Fehlings has collaborated with scholars based in Singapore, United States and Germany. Frequent co-authors include Evan W. Newell, Alessandra Nardin, Yannick Simoni, Hermi Sumatoh, Maxim N. Artyomov, Cora D. Arthur, Elise Alspach, Robert S. Fulton, Olga Malkova and Catrina C. Fronick. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Scientific Reports, Current Opinion in Immunology, Nature Communications and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact